Real-world use of semaglutide for weight management: patient characteristics and dose titrationA danish cohort study
For fiscal years 2019 through 2023, the FDA approved 99% of the approximately 18,000 single-patient expanded access Investigational New Drug requests, according to FDA data
Liraglutide, sold under the brand name Victoza, is an anti-diabetic medication used to treat type-2 diabetes, obesity, and chronic weight management
Below 2C risks ice crystal formation that mechanically damages peptide chains
Other weight management medications may be available as well, depending on your specific health profile
After 6 weeks, participants completed another web-based survey that repeated the PROMs and included a fatigue global rating of change (GRC) item, with responses ranging from Much Worse to Much better